DIABESITY DIALOGUES | Patient Perspectives for PCPs: Tackling the Treatment Paradigms of Obesity, T2D, and Other Metabolic Disorders is organized by Healio.
Release Date: June 09, 2023
Expiration Date: June 08, 2024
Activity Description;
There is an urgent need for effective intervention by healthcare professionals (HCPs) to address the twin epidemics of Type 2 diabetes (T2D) and obesity. Tune into the Diabesity Dialogues vodcast, where renowned physicians, Dr. Robert Kushner, MD, and Dr. Jamy Ard, MD, provide valuable insights on treatment initiation, intensification, and the effective management of diabesity in the presence of other comorbidities. Hear how our esteemed hosts harness the power of social media discuss the latest information on GLP-1 receptor agonists (RA) and dual GIP/GLP-1 RAs and dispel potential misinformation. In this special feature, tune into patient voices from social media and learn practical tips to enhance patient-centered care and be at the forefront of transformative practices. Don't miss this opportunity to join this cutting-edge conversation.
Educational Objectives:
After completing this CE activity, the participant should be better able to:
• Plan strategies to address unmet needs, including treatment initiation and escalation for patients with T2D and obesity/overweight and other comorbidity risks
• Assess the clinical implications of evidence regarding the incretin effect and the roles of GLP-1 RAs, and dual GLP-1 and GIP in treatment regimens for T2D and obesity
• Relate the pathophysiology of GLP-1 RAs as well as dual GLP-1 and GIP to the benefits of agonism of multiple receptors that affect energy homeostasis and the MOA of novel therapies for patients with T2D, obesity, and other comorbidity risks
• Implement the use of novel single and dual agonists in treatment regimens for T2D and weight loss
• Interpret the clinical implications of the efficacy and safety data of novel single and dual agonists for T2D